Stockholders' Equity

3 Months Ended

Apr. 30, 2023

Equity [Abstract]

Stockholders' Equity

Note 7: Stockholders’ Equity

The Company has a stock-based compensation plan, the 2015 Equity Incentive Plan, pursuant to which it has granted incentive and nonstatutory stock options and restricted stock units. Additionally, the Company's 2015 Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of common stock at a discounted price through payroll deductions.

Stock Options. Stock option activity for the three months ended April 30, 2023 was as follows:

			Weighted-Average		Aggregate
	Shares		Exercise Price		Intrinsic Value
	(in thousands)		Per Share		(in thousands)
Balance as of January 31, 2023		1,217	$	9.93	$	5,949
Granted		—	$	—
Exercised		(25)	$	3.49
Balance as of April 30, 2023		1,192	$	10.06	$	3,876
Vested and exercisable as of April 30, 2023		1,044	$	9.28	$	3,827

The aggregate intrinsic value of vested options exercised during the three months ended April 30, 2023 and 2022 was $0.2 million and $0.6 million, respectively. There were no stock options granted during the three months ended April 30, 2023. The weighted-average grant date fair value of options granted during the three months ended April 30, 2022 was $8.06 per share.

Restricted Stock Units. RSU activity for the three months ended April 30, 2023 was as follows:

	Shares (in thousands)		Weighted-Average Grant Date Fair Value Per Share
Balance as of January 31, 2023		1,466	$	15.81
Granted		980	$	13.15
Vested		(178)	$	15.26
Canceled		(21)	$	15.60
Balance as of April 30, 2023		2,247	$	14.70

Employee Stock Purchase Plan. During each of the three months ended April 30, 2023 and 2022, employees purchased 0.1 million shares at a weighted-average price of $10.60 and $10.22 per share, respectively.